NMRD — Nemaura Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- $19.51m
- $0.08m
Annual cashflow statement for Nemaura Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.45 | -4.16 | -6.26 | -13.9 | -14.1 |
| Depreciation | |||||
| Non-Cash Items | 0.464 | 0.578 | 2.12 | 7.33 | 6.39 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.394 | 0.078 | -1.96 | -0.175 | -1.14 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.56 | -3.45 | -6 | -6.5 | -8.45 |
| Capital Expenditures | -0.08 | -0.211 | -0.836 | -0.956 | -0.539 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | 4.48 | — | — | — | — |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 4.4 | -0.211 | -0.836 | -0.956 | -0.539 |
| Financing Cash Flow Items | -0.489 | -0.04 | -2.56 | -0.051 | -0.738 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.05 | 0.097 | 38 | -6.37 | 2.08 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.92 | -3.63 | 31.8 | -14.1 | -7.64 |